Phase I Trial: T4 Immunotherapy of Head and Neck Cancer
NCT01818323
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Head and Neck Cancer
Interventions
OTHER:
Intra-tumoral T4 immunotherapy
Sponsor
King's College London
Collaborators
[object Object]